arcitumomab

arcitumomab

CEA scan Immunology A 99mTc-labelled murine IgG monoclonal Fab fragment which attaches in vivo to CEA and can be used as a tumor marker to detect GI tract CAs using immunoscintigraphy See Monoclonal antibody.

In 1996, Immunomedics received FDA and European regulatory approval for arcitumomab (CEA-Scan(R)), a diagnostic imaging kit comprised of a small antibody fragment against CEA that targeted a diagnostic isotope to sites of colorectal cancer.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.